AJP - Regulatory, Integrative and Comparative Physiology, Vol 261, Issue 2 323-R328, Copyright © 1991 by American Physiological Society

ARTICLES

Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function

M. A. Perrella, F. L. Hildebrand Jr, K. B. Margulies and J. C. Burnett Jr
Department of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905.

The endothelium has emerged as an important modulator of vascular tone by producing both vasodilating and vasoconstricting substances. In vitro studies have demonstrated that endothelial cells produce endothelium-derived relaxing factor (EDRF), which promotes vasodilation via the stimulation of intracellular guanosine 3',5'-cyclic monophosphate (cGMP). However, the role of EDRF in the basal regulation of cardiopulmonary and renal function is not well defined. The present study was therefore designed to assess the function of EDRF by studying two groups of normal anesthetized dogs, of which one received a competitive inhibitor to EDRF generation, NG-monomethyl-L-arginine (L-NMMA; 50 micrograms.kg-1.min-1 iv), and the other received a vehicle. The L-NMMA infusion produced no significant increase in mean arterial pressure but marked increases in systemic, pulmonary, and renal vascular resistances compared with the vehicle group. Although renal blood flow decreased with L-NMMA, no changes were observed in glomerular filtration rate or sodium excretion. Associated with the cardiopulmonary and renal responses with L-NMMA was a modest increase in plasma endothelin (7.9 +/- 1.3 to 10.2 +/- 1.8 pg/ml, P less than 0.05), an endothelium-derived vasoconstrictor. No alteration was observed in plasma or urinary cGMP with EDRF inhibition. These cardiopulmonary and renal responses with L-NMMA may be attributed not only to EDRF inhibition but to an imbalance between endothelium-derived relaxing and contracting factors.

This article has been cited by other articles:

				F. L. Martin, T. Supaporn, H. H. Chen, S. M. Sandberg, Y. Matsuda, M. Jougasaki, and J. C. Burnett Jr. Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1580 - R1585. [Abstract] [Full Text] [PDF]

				A. Sener and F. G. Smith Glomerular and tubular responses to NG-nitro-L-arginine methyl ester are age dependent in conscious lambs Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1512 - R1520. [Abstract] [Full Text] [PDF]

				T. V. Peterson, C. Emmeluth, and P. Bie Renal effects of nitric oxide synthase inhibition in conscious water-loaded dogs Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R584 - R590. [Abstract] [Full Text] [PDF]

				A. Cases, J. Haas, J. C. Burnett, and J. C. Romero Hemodynamic and renal effects of acute and progressive nitric oxide synthesis inhibition in anesthetized dogs Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R143 - R148. [Abstract] [Full Text] [PDF]

				V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF]

				M. A. Pontari and M. R. Ruggieri Sex differences and role of nitric oxide in blood flow of canine urinary bladder Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R407 - R413. [Abstract] [Full Text] [PDF]

				S. K. Laycock, T. Vogel, P. R. Forfia, J. Tuzman, X. Xu, M. Ochoa, C. I. Thompson, A. Nasjletti, and T. H. Hintze Role of Nitric Oxide in the Control of Renal Oxygen Consumption and the Regulation of Chemical Work in the Kidney Circ. Res., June 29, 1998; 82(12): 1263 - 1271. [Abstract] [Full Text] [PDF]

				A. L. Hyman, Q. Hao, A. Tower, P. J. Kadowitz, H. C. Champion, B. Gumusel, and H. Lippton Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1218 - H1229. [Abstract] [Full Text] [PDF]

				B. Gumusel, Q. Hao, A. L. Hyman, P. J. Kadowitz, H. C. Champion, J. K. Chang, J. L. Mehta, and H. Lippton Analysis of responses to adrenomedullin-(13---52) in the pulmonary vascular bed of rats Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1255 - H1263. [Abstract] [Full Text] [PDF]

				W. Steudel, F. Ichinose, P. L. Huang, W. E. Hurford, R. C. Jones, J. A. Bevan, M. C. Fishman, and W. M. Zapol Pulmonary Vasoconstriction and Hypertension in Mice With Targeted Disruption of the Endothelial Nitric Oxide Synthase (NOS 3) Gene Circ. Res., July 19, 1997; 81(1): 34 - 41. [Abstract] [Full Text]

				A. Lerman, D. R. Holmes Jr, M. R. Bell, K. N. Garratt, R. A. Nishimura, and J. C. Burnett Jr Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans Circulation, November 1, 1995; 92(9): 2426 - 2431. [Abstract] [Full Text]

				Y. Hirata, H. Hayakawa, Y. Suzuki, E. Suzuki, H. Ikenouchi, O. Kohmoto, K. Kimura, K. Kitamura, T. Eto, K. Kangawa, et al. Mechanisms of Adrenomedullin-Induced Vasodilation in the Rat Kidney Hypertension, April 1, 1995; 25(4): 790 - 795. [Abstract] [Full Text]